Enovis ENOV
NYSE ENOV
$18.60 -0.43 (-2.26%)
As of: Sep 10, 2026 · 12:40 PM EDT

Enovis (ENOV) Asset Writedowns and Impairment (2018 - 2025)

Enovis' (ENOV) quarterly Asset Writedowns and Impairment came in at $501.3 million in Q4 2025, down 22.25% year-over-year from $644.8 million in Q4 2024, and down 8.59% quarter-over-quarter from $548.4 million in Q4 2025.

Analysis

Enovis (ENOV) Asset Writedowns and Impairment (2018 - 2025) Analysis & Trends

Enovis (ENOV) has reported Asset Writedowns and Impairment for 6 consecutive years, with $501.3 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 22.25% year-over-year to $501.3 million in Q4 2025; TTM through Dec 2025 was $1.7 billion, a 160.57% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 61.42% from the prior year.
  • Asset Writedowns and Impairment was $501.3 million for Q4 2025 at Enovis, down from $548.4 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $644.8 million in Q4 2024 and troughed at -$67.8 million in Q2 2024.
  • A 3-year average of $242.9 million and a median of $73.4 million in 2024 frame the typical range for Asset Writedowns and Impairment.
  • The widest YoY moves for Asset Writedowns and Impairment: up 41.19% in 2024, down 30.5% in 2024.
  • Over 3 years, Asset Writedowns and Impairment stood at -$52.0 million in 2023, then surged by 1340.12% to $644.8 million in 2024, then retreated by 22.25% to $501.3 million in 2025.
  • The last three Asset Writedowns and Impairment figures came in at $501.3 million (Q4 2025), $548.4 million (Q4 2025), and $644.8 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn
10 Enovis 1.07 Bn 1.06 Bn 359.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 501.31 Mn
Oct 3, 2025 548.44 Mn
Dec 31, 2024 644.75 Mn
Jun 28, 2024 -67.85 Mn
Mar 29, 2024 73.40 Mn
Jun 30, 2023 -51.99 Mn
Mar 31, 2023 51.99 Mn
Apr 3, 2020 449.00 Mn
Dec 31, 2019 -481.00 Mn
Jun 28, 2019 481.00 Mn
Dec 31, 2018 7.09 Mn